Belimumab after rituximab as maintenance therapy in lupus nephritis

Rheumatology (Oxford). 2014 Nov;53(11):2122-4. doi: 10.1093/rheumatology/keu369. Epub 2014 Sep 8.

Authors

Tineke Kraaij¹, Tom W J Huizinga¹, Ton J Rabelink¹, Y K Onno Teng²

Affiliations

¹ Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. y.k.o.teng@lumc.nl.

PMID: 25205827
DOI: 10.1093/rheumatology/keu369

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antigens, CD20
Female
Follow-Up Studies
Humans
Immunologic Factors / therapeutic use
Lupus Nephritis / drug therapy*
Male
Rituximab

Substances

Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Immunologic Factors
Rituximab
belimumab